Targeting Solid Tumors with pH-Dependent TCE: First in Human Development of CT-202 Publications Apr 20 Written by Martin Lehr Nectin Martin Lehr Next Next A Phase 1, First-in-Human Study of CT-95, a Mesothelin-Directed Bispecific T Cell Engager (TCE) in Subjects with Advanced Solid Tumors
Targeting Solid Tumors with pH-Dependent TCE: First in Human Development of CT-202 Publications Apr 20 Written by Martin Lehr Nectin Martin Lehr
